Misplaced Pages

Clemeprol

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Antidepressant drug

Pharmaceutical compound
Clemeprol
Clinical data
Other namesBRL 14342
Identifiers
IUPAC name
  • 1-(3-chlorophenyl)-3-(dimethylamino)-1-phenylpropan-2-ol
CAS Number
PubChem CID
ChemSpider
ChEMBL
Chemical and physical data
FormulaC17H20ClNO
Molar mass289.80 g·mol
3D model (JSmol)
SMILES
  • CN(C)CC(C(C1=CC=CC=C1)C2=CC(=CC=C2)Cl)O
InChI
  • InChI=InChI=1S/C17H20ClNO/c1-19(2)12-16(20)17(13-7-4-3-5-8-13)14-9-6-10-15(18)11-14/h3-11,16-17,20H,12H2,1-2H3
  • Key:KGSABFQIAANNPS-UHFFFAOYSA-N

Clemeprol is an serotonin–norepinephrine reuptake inhibitor (SNRI) antidepressant and anticholinergic agent.

It is an enantiomeric mixture of R and S isomers. Both isomers show similar pharmacological activity.

Synthesis

A synthetic pathway for clemeprol is disclosed:

Clemeprol synthesis
Clemeprol synthesis

The Corey-Chaykovsky epoxidation between 3-chlorobenzophenone (1) and dimethylsulfoxonium methylide (Corey's reagent) , gives 2-(3-chlorophenyl)-2-phenyloxirane (2). Further reaction with boron trifluoride etherate gives m-chlorophenyl-phenylacetaldehyde, PC12549135 (3). A second Corey-Chaykovsky epoxidation gives 2-oxirane, PC12549073 (4). Quenching with dimethylamine completes the synthesis of clemeprol (5).

See also

References

  1. Dictionary of Pharmacological Agents By C.R. Ganellin, David J. Triggle.
  2. Clark MS, Johnson AM, McClelland GR, Nelson DR (December 1980). "Pharmacological and biochemical properties of BRL 14342, a novel potential antidepressant drug". Neuropharmacology. 19 (12): 1207–8. doi:10.1016/0028-3908(80)90203-8. PMID 7442949.
  3. Koch, H., Drugs Future, 1983,8, 194.
  4. Clark JA, Clark MS, Gardner DV, Gaster LM, Hadley MS, Miller D, et al. (November 1979). "Substituted 3-amino-1,1-diaryl-2-propanols as potential antidepressant agents". Journal of Medicinal Chemistry. 22 (11): 1373–9. doi:10.1021/jm00197a018. PMID 533885.
  5. Anon., GB1448437 (1976-09-08 to Beecham Group Ltd).
  6. Judith Ann Clark, US4101676 & US4113972 (1978 to Beecham Group PLC).
  7. Judith Ann Clark, US4056630 (1977 to Beecham Group PLC).
  8. CA1049530 idem Judith Ann Clark, US4028415 (1977 to Beecham Group PLC).
Antidepressants (N06A)
Specific reuptake inhibitors and/or receptor modulators
SSRIsTooltip Selective serotonin reuptake inhibitors
SNRIsTooltip Serotonin–norepinephrine reuptake inhibitors
NRIsTooltip Norepinephrine reuptake inhibitors
NDRIsTooltip Norepinephrine–dopamine reuptake inhibitors
NaSSAsTooltip Noradrenergic and specific serotonergic antidepressants
SARIsTooltip Serotonin antagonist and reuptake inhibitors
SMSTooltip Serotonin modulator and stimulators
Others
Tricyclic and tetracyclic antidepressants
TCAsTooltip Tricyclic antidepressants
TeCAsTooltip Tetracyclic antidepressants
Others
Monoamine oxidase inhibitors
Non-selective
MAOATooltip Monoamine oxidase A-selective
MAOBTooltip Monoamine oxidase B-selective
Adjunctive therapies
Miscellaneous
Anxiolytics (N05B)
5-HT1ARTooltip 5-HT1A receptor agonists
GABAARTooltip GABAA receptor PAMsTooltip positive allosteric modulators
Hypnotics
Gabapentinoids
(α2δ VDCC blockers)
Antidepressants
Antipsychotics
Sympatholytics
(Antiadrenergics)
Others
Neuropathic pain and fibromyalgia pharmacotherapies
Monoaminergics
Ion channel blockers
Others
Monoamine reuptake inhibitors
DATTooltip Dopamine transporter
(DRIsTooltip Dopamine reuptake inhibitors)
NETTooltip Norepinephrine transporter
(NRIsTooltip Norepinephrine reuptake inhibitors)
SERTTooltip Serotonin transporter
(SRIsTooltip Serotonin reuptake inhibitors)
VMATsTooltip Vesicular monoamine transporters
Others
See also: Receptor/signaling modulatorsMonoamine releasing agentsAdrenergicsDopaminergicsSerotonergicsMonoamine metabolism modulatorsMonoamine neurotoxins
Portal: Categories: